Calcitriol Protection against Dopamine Loss Induced by Intracerebroventricular Administration of 6-Hydroxydopamine

By Smith Michael   Fletcher-Turner Anita   Yurek David   Cass Wayne  

Neurochemical Research, Vol. 31, Iss. 4, 2006-04 ,pp. : 533-539

Springer Publishing Company

Access to resources Recommend Favorite

Characterization of Enhanced Behavioral Responses tol-DOPA Following Repeated Administration in the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease

By Henry B.   Crossman A.R.   Brotchie J.M.  

Experimental Neurology, Vol. 151, Iss. 2, 1998-06 ,pp. : 334-342

Elsevier

Access to resources Recommend Favorite

Recombinant Adeno-associated Viral Vector-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Protects Nigral Dopamine Neurons after Onset of Progressive Degeneration in a Rat Model of Parkinson's Disease

By Mandel R.J.   Snyder R.O.   Leff S.E.  

Experimental Neurology, Vol. 160, Iss. 1, 1999-11 ,pp. : 205-214

Elsevier

Access to resources Recommend Favorite

Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies

By Chaturvedi R.K.   Agrawal A.K.   Seth K.   Shukla S.   Chauhan S.   Shukla Y.   Sinha C.   Seth P.K.  

International Journal of Developmental Neuroscience, Vol. 21, Iss. 7, 2003-11 ,pp. : 391-400

Elsevier

Access to resources Recommend Favorite

Differential Involvement of Intracellular Ca²⁺ in 1-Methyl-4-phenylpyridinium- or 6-Hydroxydopamine-Induced Cell Viability Loss in PC12 Cells

By Lee Dong   Han Young   Han Eun   Bang Hyoweon   Lee Chung  

Neurochemical Research, Vol. 31, Iss. 7, 2006-07 ,pp. : 851-860

Springer Publishing Company

Access to resources Recommend Favorite